Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Amgen
Amgen
News Correspondent
By
Coins2Day Editors
November 4, 2025
News Correspondent
By
Coins2Day Editors
August 5, 2025
News Correspondent
By
Coins2Day Editors
May 1, 2025
News Correspondent
By
Coins2Day Editors
February 4, 2025
Conferences
AI is in the early stages of upending the drug discovery and development process, but there will still need to be a ‘lab in the loop’
By
Sage Lazzaro
December 14, 2023
Health
How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own
By
Arthur Allen
and
KFF Health News
April 13, 2023
Magazine
Big Hospitals vs. Big Pharma: Which industry is most to blame for soaring health care costs?
By
Geoff Colvin
April 8, 2021
Newsletters
Inclusion in the Dow does not guarantee a bump to your share price
By
Katherine Dunn
and
Alan Murray
August 27, 2020
Newsletters
Can the Dow’s Big Tech makeover finally push the blue chip index above 30,000?
By
Bernhard Warner
August 25, 2020
Finance
Salesforce, Amgen, and Honeywell Int’l will join Dow Jones Industrial Average
By
Andrew Nusca
August 24, 2020
Conferences
Amgen CEO is ‘optimistic’ about COVID-19 clinical trials
By
Aaron Pressman
July 7, 2020
Newsletters
U.S. Biotech Amgen Strikes Major Deal to Expand China Presence
By
Sy Mukherjee
October 31, 2019
Health
3 Drug Giants Win a Legal Victory Against Trump—For Now: Brainstorm Health
By
Sy Mukherjee
July 9, 2019
Health
Big Drug Makers Sue to Block Mandatory Price Disclosures in TV Ads: Brainstorm Health
By
Sy Mukherjee
June 14, 2019
Health
The FDA Approved a Promising New Drug to Treat Migraines. Now, the Drugmakers’ Stock Prices Are Rising
By
David Meyer
May 18, 2018
Most Popular
Economy
'I just don't have a good feeling about this': Top economist Claudia Sahm says the economy quietly shifted and...
By
Eleanor Pringle
Future of Work
Ford CEO has 5,000 open mechanic jobs with up to 6-figure salaries from the shortage of manually skilled workers: 'We...
By
Marco Quiroz-Gutierrez
Big Tech
The Chan Zuckerberg Initiative cut 70 jobs as the Meta CEO’s philanthropy goes all in on mission to 'cure or prevent...
By
Sydney Lake